Clinical Trial Update: Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes and Renal Impairment [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacodynamic and pharmacokinetic effects of LX4211 in subjects with Type 2 Diabetes Mellitus and renal impairment. The trial sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Impairment
• Type 2 Diabetes Mellitus

Drugs mentioned

• LX4211 (LX4211)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus, Renal Impairment | Phase 1 | Status: COMPLETED